WNL Biomedtech announced that it has received funding from Huaying Capital, ChengDu ShengNuo Biotec Co.,Ltd.

Cheng Du Sheng Nuo Biotec Co Ltd is a China-based company mainly engaged in the research and development of peptide active pharmaceutical ingredients (APIs) and preparation products. The Company's products target areas including immunology, digestive tract, antivirus, gynecology, diabetes, cardio-cerebrovascular, rare diseases, orthopedics and other fields. The Company is also engaged in customized peptide production services for customers, customized production services for peptide APIs and preparations, and technology transfer services for peptide drug production. The Company also provides small-molecule chemical drug Levosimendan preparations on behalf of processing, Levosimendan bulk drug production and export sales business.